Home / Clinical Laboratory / Controls / Control / Assayed Control Acusera™ Premium Plus Multiple Analytes Tri-Level 12 X 15 mLIA3112
Picture of Assayed Control Acusera™ Premium Plus Multiple Analytes Tri-Level 12 X 15 mLIA3112

Assayed Control Acusera™ Premium Plus Multiple Analytes Tri-Level 12 X 15 mLIA3112

Assayed-Control-Acusera™-Premium-Plus-Multiple-Analytes-Tri-Level-12-X-15-mLIA3112

SKU #

#1103086

MPN #

IA3112

Brand

Randox Laboratories Ltd USA

Stock

In Stock

Quantity

100

Features

CONTROL, IMMUNOASSAY PREMIUM PLUS TRI-LEVEL 12X15ML D/S

$777.97 USD

Product Specifications Product Usage Additional Information
Print
Attribute Name Attribute Value
McKesson # 1103086
Manufacturer # IA3112
Brand Acusera™ Premium Plus
Manufacturer Randox Laboratories Ltd USA
Application Control
For Use With For Monitoring The Accuracy and Reproducibility of 54 Analytes
Form Lyophilized
Levels Tri-Level
Test Name Multiple Analytes
Test Type Assayed
UNSPSC Code 41116128
Volume 12 X 15 mL
Compare Selected Items Email

Similar Items

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

  • Lyophilized for enhanced stability
  • 100% Human serum
  • Stable to expiry date at 2 to 8° C
  • Assayed, instrument specific target values provided for up to 51 parameters
  • Contains routinely run tumour markers: AFP/CA15-3/CA19-9/CA-125/CEA/PSA/Free-PSA
  • The unique combination of routine tumour markers, therapeutic drugs and Vitamin D allows laboratories to dramatically reduce the number of controls required while ultimately keeping costs to a minimum